Ketoconazole Cristers

Ketoconazole, the active ingredient in Ketoconazole Cristers, is an azole antifungal presented as a topical formulation for skin use. It treats superficial fungal infections such as tinea corporis, tinea cruris, tinea pedis, seborrheic dermatitis, and pityriasis versicolor in both adults and children.

GNH USA supplies Ketoconazole Cristers as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export to EU and other markets.

Ketoconazole is used topically to treat fungal skin conditions by inhibiting the growth of dermatophytes and yeasts. - Tinea corporis: clears ring‑shaped lesions and reduces itching. - Tinea cruris: eliminates fungal overgrowth in the groin area and relieves irritation. - Tinea pedis: resolves athlete’s foot symptoms and prevents recurrence. - Seborrheic dermatitis: controls scalp flaking and erythema caused by Malassezia species. - Pityriasis versicolor: diminishes discolored patches and restores normal skin tone.

Topical ketoconazole may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Burning or stinging sensation at the application site. - Itching or mild pruritus. - Redness or erythema. - Dryness or peeling of the skin. - Scaling or flaking.

Serious or Rare Side Effects: - Severe allergic reaction (angioedema, swelling, difficulty breathing). - Contact dermatitis with vesiculation. - Hepatotoxicity (rare with extensive use). - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Photosensitivity leading to exaggerated sunburn.

When using Ketoconazole Cristers, consider the following precautions to ensure safe and effective therapy. - Apply to intact skin only: avoid broken or inflamed areas to reduce systemic absorption. - Limit duration of use: follow prescriber guidance, typically no longer than 2–4 weeks. - Avoid occlusive dressings: they may increase drug penetration and irritation. - Monitor for signs of allergy: discontinue if rash or swelling develops. - Use with caution in hepatic impairment: systemic exposure can be higher. - Store below 25°C: keep in the original container, protect from moisture and light.

Ketoconazole can interact with other agents, primarily through its effect on cytochrome P450 enzymes and local skin absorption.

Major Interactions (Avoid): - Systemic azole antifungals (e.g., oral itraconazole): concurrent use may increase systemic ketoconazole levels and toxicity. - CYP3A4 substrates with narrow therapeutic index (e.g., cyclosporine, tacrolimus): risk of elevated plasma concentrations if significant systemic absorption occurs. - Topical corticosteroids containing ketoconazole: may enhance local irritation.

Moderate Interactions (Monitor Closely): - Other topical antifungals (e.g., clotrimazole): assess for additive irritation. - Warfarin: monitor INR if extensive skin application leads to systemic exposure. - Hormonal contraceptives: rare reports of reduced efficacy; advise alternative contraception if prolonged use.